The targets of the inflammatory response in multiple sclerosis (MS) are myelin and the myelin producing cells, oligodendrocytes. The infiltration of activated immune cells and recruitment of endogenous glia lead to the destruction of myelin and oligodendrocytes, a process that is compounded by the release of cytokines by infiltrating cells. Recent evidence suggests that key cytokines that are responsible for the destruction of myelin may also mediate the process of remyelination and repair. It appears that both inflammatory and repair processes are governed by the temporal and spatial relation of cytokines to their targets.
Freedman MS , D'Souza S , Antel JP. (1997) Gamma delta T-cell-human glial cell interactions. I. In vitro induction of gammadelta T-cell expansion by human glial cells . J Neuroimmunol74: 135-142 .
2.
Liuzzi GM , Riccio P , Dal Canto MC. (1995) Release of myelin basic protein-degrading proteolytic activity from microglia and macrophages after infection with Theiler's murine encephalomyelitis virus: comparison between susceptible and resistant mice . J Neuroimmunol62: 91-102 .
3.
Antel JPet al. (1994) Oligodendrocyte lysis by CD4+ T cells independent of tumor necrosis factor . Ann Neurology35: 341-348 .
Selmaj K , Raine CS , Cannella B , Brosnan C. (1991) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis . J Clin Invest87: 949-954 .
6.
Mitrovic Bet al. (1995) Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes . Neurosci65: 531-539 .
7.
Oka A , Belliveau MJ , Rosenberg PA , Volpe JJ. (1993) Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention . J Neuroscience13: 1441-1453 .
8.
Husain J , Juurlink BH.Oligodendroglial precursor cell susceptibility to hypoxia is related to poor ability to cope with reactive oxygen species . Brain Res698: 86-94 .
9.
Raine CS. (1997) The Norton Lecture: a review of the oligodendrocyte in multiple sclerosis lesion . JNeuroimmunol77: 135-152 .
10.
Raine CS , Wu E. (1993) Multiple sclerosis: remyelination in acute lesions . J Neuropathol Exp Neurol52: 199-204 .
11.
Knapp PE. (1997) Injury stimulates outgrowth and motility of oligodendrocytes grown in vitro . Exp Cell Res234: 7-17 .
12.
Loughlin AJet al. (1997) Myelination and remyelination of aggregate rat brain cell cultures enriched with macrophages . J Neurosci Res47: 384-392 .
13.
Hofman FM , Hinton DR , Johnson K , Merrill JE. (1989) Tumor necrosis factor identified in multiple sclerosis brain . J Exp Med170: 607-612 .
14.
Sharief MK , Hentges R. (1991) Association between tumor necrosis factor-a and disease progression in patients with multiple sclerosis . N Eng J Med325: 467-472 .
15.
Tsukada Net al. (1991) Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis . J Neurol Sci102: 230-234 .
16.
Riechman Pet al. (1995) TNF-a messenger RNA expression in patients with relapsing remitting multiple sclerosis is associated with disease activity . Ann Neurol37: 82-88 .
17.
Hartung HPet al. (1995) Circulating adhesion molecules and inflammatory mediators in demyelination: a review . Neurology45(suppl 6); S22-S32 .
18.
Wong GH. (1995) Protective roles of cytokines agianst radiation: induction of mitochondial Mn SOD . Biochem Biophys Acta1271: 205-209 .
19.
Bruce AJet al. (1996) Altered neuronal and microglial responses to excitotoxic and ischemic brain injury to mice lacking TNF receptor . Nature Med2: 788-794 .
20.
Cheng B , Mattson MP. (1994) Tumour necrosis factor protects neurons against excitotoxic/metabolic insults and promotes maintainance of calcium homeostasis . Neuron12: 139-153 .
Vandanabeele P , DePercq W , Beyaert R , Fiers W. (1995) Two tumor necrosis factor receptors: structure and functions . Trends Biochem Sci5: 392-399 .
23.
Rothwell N , Allan S , Toulmond S. (1997) The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications . JClin Invest100: 2648-2652 .
24.
Brosnan CF , Cannell B , Battistini L , Raine CS. (1995) Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species . Neurology45(suppl 6): S16-S21 .
25.
Friedlander RM , Gagliardini V , Rotello RJ , Yuan J. (1996) Functional role of IL-1b and IL-1b-converting enzyme-mediated apoptosis . J Exp Med184: 717-724 .
26.
Parkinson J , Mitrovic B , Merrill JE. (1997) The role of nitric oxide in multiple sclerosis . J Mol Med75: 174-186 .
27.
Heuschling P. (1995) Nitric oxide modulates gamma-interferon-induced class II antigen expression on rat astrocytes . J Neuroimmunol57: 63-69 .
28.
Merrill JE , Benveniste EN. (1996) Cytokines in inflammatory brain lesions: helpful and harmful . TINS19: 331-338 .
29.
van Snick JV. (1990) Interlukin-6: an overview . Ann Rev Immunol8: 253-278 .
30.
Perez Let al. (1995) B cells capable of spontaneous IgG secretion in cerebrospinal fluid from patients with multiple sclerosis: Dependency on local IL-6 production . Clin Exp Immunol101: 449-452 .
31.
Maimone D , Guazzi GC , Annunziata P. (1997) IL-6 detection in multiple sclerosis brain . J Neurol Sci146: 59-65 .
32.
Diab A , et al. (1997) High IL-6 and low IL-10 in the central nervous system are associated with protracted relapsing EAE in DA rats . J Neuropathol Exp Neurol56: 641-650 .
33.
Peress NS , Perillo E , Seidman RJ. (1996) Glial transforming growth factor. (TGF)-beta isotypes in multiple sclerosis: Differential glial expression of TGF-beta1, 2 and 3 isotypes in multiple sclerosis . J Neuroimmunol71: 115-123 .
34.
Mokhtarian Fet al. (1994) Defective production of anti-inflammatory cytokine, TGF-b by T cell lines of patients with active multiple sclerosis . J Immunol152: 6003-6010 .
35.
Link J. (1994) Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis . Acta Neurol Scand90(suppl 158): 1-58 .
